Stercuronium iodide
Clinical data
Other namesMYC-1080; MYSC-1080
Identifiers
  • (3β)-N-Ethyl-N,N-dimethylcona-4,6-dienin-3-aminium iodide
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC26H43IN2
Molar mass510.548 g·mol−1
3D model (JSmol)
  • CC[N+](C)(C)[C@H]1CC[C@@]2([C@H]3CC[C@]45CN([C@H]([C@H]4CC[C@H]5[C@@H]3C=CC2=C1)C)C)C.[I-]
  • InChI=1S/C26H43N2.HI/c1-7-28(5,6)20-12-14-25(3)19(16-20)8-9-21-23(25)13-15-26-17-27(4)18(2)22(26)10-11-24(21)26;/h8-9,16,18,20-24H,7,10-15,17H2,1-6H3;1H/q+1;/p-1/t18-,20-,21+,22+,23-,24-,25-,26-;/m0./s1
  • Key:NZMZXOUHSHDAQQ-VIGAWJBNSA-M

Stercuronium iodide (INN, USAN) (developmental code names MYC-1080, MYSC-1080) is an aminosteroid neuromuscular blocking agent which was never marketed.[1][2] It acts as a competitive antagonist of the nicotinic acetylcholine receptor (nAChR), and is also reported to be an acetylcholinesterase inhibitor.[1]

References

  1. ^ a b Kar A (2005). Medicinal Chemistry. New Age International. pp. 175–. ISBN 978-81-224-1565-0.
  2. ^ Bowden RE, Collier B, Dripps RD, Duchen LW, Enderby GE, Ginsborg BL, Head S, Hobbiger F, Jenkinson DM, MacIntosh, Smith SE (13 March 2013). Neuromuscular Junction. Springer Science & Business Media. pp. 421–. ISBN 978-3-642-45476-9.


Categories